A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

NCT00150644 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids
Leiomyoma

Interventions

DRUG: Asoprisnil
DRUG: Asoprisnil
DRUG: Placebo

Sponsor

Abbott